Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Porky, will you be adding more shares or selling?
How has it increased? Deluded.
Only the CEO gets paid the most and the rest don't get much at all. I would imagine they will get share options moving forward with a lower salary so would need to deliver first. We don't have a second CEO claiming a salary at the moment so talking nonsense as usual.
@IM - A stock is NOT always cheap because its SP goes down.
This stock is VERY expensive based on where the business is at today and now has FOUR more non execs to feed whilst the new BOD is decided on.
NOT one of the four directors that needs to go has gone meanwhile cash burn has increased.
Every silver lining has a cloud, when it comes to Rasher.
Maybe you should experiment with micro-dosing, you miserable t**t ;-)
This news would never suit porky, as he wanted a cheap entry from the carnage of sacking the whole bod in one go. I’m glad he’s not happy.
Official information below and not Porky's nonsense. He lost it all on 4D so nothing will change with him ever.
Cash runway now appears sufficient to carry it well into 2025
Full year 2023E Group net losses along with the cost of establishing/facilitating Inaphaea Biolabs (including the
acquisition of Imagen Therapeutics), resulted in an average estimated cash burn of a little over £200,000/month for
the period. If one now prudently assumes further, albeit somewhat reduced, Group net losses for 2024E, during
which time it utilises the newly raised net funding to accelerate exploitation and integration of its acquired BioBank
materials in tandem with commercial development/brand establishment within Inaphaea while also advancing
its preclinical product pipeline in the absence of further cash acquisition(s), the Group now appears to have runway
sufficient to carry it into Q2 2025.
Between now and then, of course, various upside scenarios suggest this period could become significantly extended.
This could be derived through securing higher volumes of fee-paying service customers for Inaphaea, potential
signing of licensing agreements with external parties willing to pay upfront charges and fund ongoing
development of the Group’s preclinical and/or clinical assets which, in turn, could also attract continuing
milestones instalments. Any such outcome could be both transformative for ValiRx’s balance sheet while also
proving its business model.
Acid test for me will be what the new BOD actually looks like ready to go into H2.
IF the entire BOD are staying including Suzy but with a different title what will be the point of this???
The raise will happen, make no mistake, with the increased costs of four more execs to feed cash burn will run out even quicker now. New BOD will need a decent cash runway from start of H2 1/7/24. There are lifestyles here that need to be maintained.
See how events unfold - Kevin, Martin and Gerry ALL still need to go and SUZY removed from a BOD position completely.
PM - revenue from the Lab does not mean free cash flow from the Lab. Surely you know that?
Expenses will go up over the years. Natural and for a biotech it is very low.
Revenue will come in through the lab. No question about that and still every chance 201 completes very soon.
Therefore Q2 2025 is likely to be significantly extended.
The problem is that Porky is correct... expenses have gone up whilst cash is not coming in. They are likely to need another raise this year despite your dreamland opinion of cash lasting until Q2 2025.
Absolute codswallop Porky. Suzy stepping aside is a huge bonus. Her wealth of knowledge as a scientist is absolutely needed.
Predictable response. Only because you have no money to buy.
That has been the same pattern since 4D fell.
Well all that has happened is the cash burn has gone up with two more non exec appointments to feed whilst we now sit and wait for a new CEO, no doubt Suzy becomes some science director still on the dam board when that event happens and probably retaining her current package - joke.
By withdrawing the Requisition Notice then i take it Smug Kevin is remaining as chairman on the board along with Martin and CFO Gerry. What was the point? We now have two more NEDS to feed on top of the two yes NEDS that Suzy proposed! You couldn't make it up. FOUR of them now to pay!!!
Frankly out of the three proposed newbies it was ONLY Benjamin Snipe that i wanted as he has vast Patent Experience and could have been useful.
Well done Kevin and Martin being able to save their ass , well done Gerry for escaping this entire event and well done Suzy you can milk it for longer now as CEO and then continue on the board with your benefits. Nice work.
Not impressed that the Requisition has been removed saving TWO that need to go just to give this Adrian guy a position on the BOD as a NED.
Stock remains Uninvestable and it will be interesting to see if they will be able to secure investor support for the placing from H2.
Thanks for your efforts, Suzy. I'm sure you gave it your best. Hopefully you'll be around to see some of your work bear fruit in time
What an amazing time for a pump and dump operation.😄
Agree the company would have been busted without Suzy and Kevin but they made a mess of it with 201 and therefore the share price. Hopefully they can seal the deal with 201 shortly. That will really move the share price big now.
She did! she removed the previous CEO & kept Co going!
Which it would not have lasted 6 months had she not! imo
If she remains within the company that will save severance pay etc. She deserves nothing like that. Perhaps a role cleaning test tubes and running the annual Grand National office sweepstake would keep her occupied.
I think 🤔 it’s a positive
Don’t know the cash situation but Suzy knows this has potential and needs some one who knows how to progress and it will
Still not an incentive to buy shares here. The crew are now engaged in rearranging the deck chairs on the Titanic while they discuss who they want to be Captain, assuming they can find a volunteer on what will have to be a pretty low salary. I'll guess some fanfare appointment in a couple of months to support a(nother) raise.
Reading her statement anyone would think she'd actually achieved something! A complete disaster and I'll be glad to see to see her gone.